TechFlow News, June 5: According to a report by The Block, blockchain analytics firm Chainalysis recently released a new report stating that as the gray-market peptide industry’s annualized market size surpasses $100 million, leading suppliers are rapidly adopting Bitcoin and stablecoins as primary settlement instruments. In Q1 2026, cryptocurrency inflows into this industry reached $32 million—a 159% quarter-on-quarter surge. Due to widespread prohibitions imposed by traditional banks and credit card payment channels on prescription-grade compounds and unregulated substances, numerous Chinese chemical manufacturers have turned to cryptocurrencies to facilitate transactions, with high-value orders particularly favoring stablecoins to mitigate price volatility risk.
Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / support@techflowpost.com ICP License: 琼ICP备2022009338号
